Coordinated induction of cyclooxygenase-2/ prostaglandin E₂ and hepatocyte growth factor by apoptotic cells prevents lung fibrosis

Medicine & Life Sciences

• 5-((2,6-dichlorobenzyl)sulfonyl)-3-((3,5-dimethyl-4-((2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-1,3-dihydro-2H-indol-2-one 31%
• 6-isopropoxy-9-oxoxanthene-2-carboxylic acid 29%
• Alveolar Macrophages 18%
• Anti-Inflammatory Agents 12%
• Bleomycin 57%
• Cyclooxygenase 2 88%
• Cyclooxygenase 2 Inhibitors 19%
• Dinoprostone 81%
• Fibrosis 62%
• Hepatocyte Growth Factor 100%
• Hydroxyproline 19%
• indium-bleomycin 22%
• Lung 44%
• N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide 24%
• Proteins 6%
• Pulmonary Fibrosis 19%
• Up-Regulation 12%